Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec

NCT02153346 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02153346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02153346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2014
Completion date
April 22, 2016
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma